U.K. Clears Gilead Drug for Covid-19 in Early-Access Program

(Bloomberg) -- The U.K. approved using Gilead Sciences Inc.’s antiviral drug remdesivir for some patients hospitalized with Covid-19 after a study showed it can speed their recovery.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.